Our study revealed novel protein-protein interactions in gastric cancer that could be used for immunotherapy (PDGFD-CXCR4; PDGFD-TAP1), but more research is still needed to understand the molecular action processes in detail. This evidence concerns the gene PDGFD and gastric cancer.